F
FibroBiologics, Inc. (FBLG)
NCM – Real Time Price. Currency in USD
1.11
+0.08 (7.77%)
At close: Aug 12, 2026, 4:00 PM EDT
1.13
+0.02 (2.01%)
After-hours: Aug 12, 2026, 4:50 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.11
+0.08 (7.77%)
At close: Aug 12, 2026, 4:00 PM EDT
1.13
+0.02 (2.01%)
After-hours: Aug 12, 2026, 4:50 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $3.5M significantly exceed its total debt $1.5M, ensuring strong financial flexibility
Total current assets $5.8M exceed Total current liabilities $2.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.3) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-576.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.64 | 6.05 | 10 | |
| Quick ratio | 2.64 | 5.63 | 10 | |
| Debt to Equity | 0.32 | 0.30 | 7.0 | |
| Debt to Assets | 0.18 | 1.04 | 8.0 | |
| Interest coverage | -576.14 | -16.91 | 1.0 | |
| Weighted average score | 7.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -94K | -437K | -573K | -832K | -863K |
| Operating Income | -4M | -9M | -14M | -17M | -17M |
| Net Income | -5M | -16M | -11M | -19M | -18M |
| EBITDA | -4M | -8M | -13M | -16M | -16M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 75.77 | 5.5 |
| Next quarter | N/A | 37 | 5.5 |
| Current year | N/A | 64.29 | 5.5 |
| Next year | N/A | -8.33 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 17.66 | -30.99 | 24.59 | 7.5 |
| Y/Y | 999 | 11.61 | 72.5 | 21.59 | 9.3 |
| 3y average | 999 | -85.54 | N/A | -60.87 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 5.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |